AmeriHealth® RxPennsylvania and West Virginia
Option IMonthly Premium: $54.30Option I provides the standard Medicare Part D prescription drug benefit (with $295 annual deductible; 25% coinsurance from $295.01 to $2,700 in total yearly costs). After the member’s yearly true out-of-pocket (TROOP) costs reach $4,350, AmeriHealth Rx members will pay the greater of 5% coinsurance or $2.40 generic and $6.00 brand copayment for the rest of the year. Option IIMonthly Premium: $58.90Option II provides a higher level of coverage than Option I. There is no deductible. Before the total yearly drug costs (paid by the member and/or plan) reach $2,700, AmeriHealth Rx members will pay the following for prescription drugs:
After you reach $2700, you pay 100% of drug costs at discounted prices through the coverage gap. After your total-out-of-pocket drug costs reach $4,350, AmeriHealth Rx members will pay the greater of 5% coinsurance or $2.40 generic and $6.00 brand copay thereafter. AmeriHealth Rx Plan Option Comparison Chart
For more complete information, see the Download the
DefinitionsPremiums Deductible Coinsurance Coverage Gap Need extra help with health plan and drug costs?If you have limited income and resources, you may qualify for low-income subsidy. When you join AmeriHealth Rx, Medicare will tell us how much extra help you are getting. Then, we will let you know the amount you will pay. If you qualify, your drug costs will also be lower. You may be able to get extra help to pay for your prescription drug premium and costs. To see if you qualify for getting extra help, call:
Please note: In some cases, Medical Assistance copays will apply. Benefits listed here are effective January 1, 2009. Benefits, formulary, pharmacy and provider networks, premiums, and/or copays may change on January 1, 2010. AmeriHealth Rx prospective members should call 1-800-898-3492 (TTY/TDD: 1-877-219-5457), seven days a week, 8 a.m. to 8 p.m., for questions related to the product. Learn more about the Best Available Evidence PolicyEarly in 2006, a number of factors contributed to the problem of incorrect cost-sharing levels for full-benefit dual eligible’s and other LIS eligible individuals. The purpose of this link is to provide members with information on CMS Best Available Evidence policy. In certain cases, CMS systems do not reflect a beneficiary’s correct low-income subsidy (LIS) status at a particular point in time. To address these situations, CMS created the Best Available Evidence (BAE) policy. This policy requires Plans to establish the appropriate cost-sharing for low-income beneficiaries when presented with evidence that the beneficiary’s information is not accurate. Learn more about the Best Available Evidence Policy. The AmeriHealth Rx Medicare contract is renewed annually. The availability of coverage beyond the end of the current contract year is not guaranteed. |